First Pavlov Saint Petersburg University
Saint Petersburg, 197342, Russia
NCT Number: NCT04582019
Evaluation of safety and effectiveness of ureteral DJ stent with magnet (Blackstar, Urotech), severity of stent-association symptoms and pain level syndrome after stent extraction compared with stent extraction by flexible cystoscope
Looking for future studies?
Notify Me18 year–70 year
Male
Interventional
Not applicable
Saint Petersburg, 197342, Russia
Inclusion criteria
Exclusion criteria
All patients will be randomized into 2 groups:
Using the Visual Analog Scale of Pain (VASP) and Ureteric Stent Symptom Questionnaire (USSQ) we are going to assess the pain syndrome and the severity of stent-associated symptoms. The USSQ will be filled twice: 3 days after stent placement and on the day of stent removal, just before the procedure. All stents will be removed 30 days after placement. Also, immediately after stent removal, patients will complete the VASP questionnaire. In the control group, the stent will be removed using flexible cystoscopy. In the experimental group under ultrasound control using a magnetic retriever, with a bladder capacity of at least 150 ml.
Primary assessed outcomes:
Secondary assessed outcomes:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
stent extraction using magnetic retriever or flexible cystoscope
Time frame: 30 days
Using USSQ to evaluate the difference of SRS in patients with different types of stent
Time frame: 30 days
Using VASP to evaluate the pain level in patients with different types of stent extraction
St. Petersburg State Pavlov Medical University
Other
A Single-center Randomized, Controlled Study Evaluating Safety and Effectiveness of Ureteral dj Stent With Magnet (Blackstar, Urotech), Stent-related Symptoms and Pain Level After Stent Removal Compared With Conventional Stent Removal With Flexible Cystoscope
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT07445646
Calculi, Female Urogenital Diseases
Zagazig, Egypt
View Trial DetailsNCT07555535
Airway Management, Female Urogenital Diseases
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT04490343
Calculi, Deep Learning Reconstruction
Amiens, France
View Trial Details